Kolexia
Peugniez Charlotte Oncologie médicale
Peugniez Charlotte
Oncologie médicale
Centre Oscar-Lambret
Lille, France
55 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Tumeurs de l'oesophage Tumeurs osseuses Tumeurs du pancréas Carcinome épidermoïde Tumeurs colorectales Encéphalopathies Lymphoedème Tumeurs du sein

Collaborateurs

Voir plus
Berger Sylvie
Berger Sylvie
Hôpital Saint Vincent de Paul Lille, Lille, France
Petit-Bourgeois Emmanuelle
Petit-Bourgeois Emmanuelle
Hôpital Saint Vincent de Paul Lille, Lille, France
Pascal Laurent
Pascal Laurent
Faculte De Medecine Et Maïeutique, Lille, France
Penel Nicolas
Penel Nicolas
Centre Oscar-Lambret, Lille, France

Industries

Voir plus
MSD
4 collaboration(s)
Dernière en 2022
GSK
4 collaboration(s)
Dernière en 2023
Lilly
3 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life Study.
The oncologist   17 septembre 2020
FOLFIRINOX de-escalation in advanced pancreatic cancer (aPC): A multicenter real-life study.
2020 ASCO Annual Meeting I   25 mai 2020
E-DIS: A Multicenter Randomized Phase II Study to Evaluate the Benefit of Chemotherapy Plus Best Supportive Care (BSC) Versus BSC in Patients With Metastatic Oesophageal Cancer of Squamous Cell-type Who Have Not Experienced a Disease Progression or Unacceptable Toxicity After a 6-weeks Chemotherapy Course .
Essai Clinique (Centre Oscar-Lambret)   14 mai 2019
Angiosarcoma in primary lymphoedema: A rare complication.
Annales de dermatologie et de venereologie   09 mars 2018
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective Study.
Clinical colorectal cancer   19 octobre 2017
Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients.
Bulletin du cancer   13 décembre 2016
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology   20 janvier 2016
Trabectedin is an effective second-line treatment in soft tissue sarcoma patients.
Annals of oncology : official journal of the European Society for Medical Oncology   24 novembre 2015
Risk factors for ifosfamide-related encephalopathy (IRE) in sarcoma (S) patients (pts).
2015 ASCO Annual Meeting I   20 mai 2015
Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.
European journal of cancer (Oxford, England : 1990)   09 décembre 2014